Virtual Medicinal Product (VMP) - Mitoxantrone 30mg/15ml solution for infusion vials
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Mitoxantrone 30mg/15ml solution for infusion vials | Start Date 19-01-2009 | End Date |
| Previous Name | Previous Name Mitoxantrone 30mg/15ml solution for injection vials | Start Date 23-06-2004 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 15.0
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- L01DB07
| BNF | Start Date | End Date |
|---|---|---|
| Current BNF 08010200 | Start Date 04-04-2022 | End Date |
| Previous BNF 08010200 | Start Date 09-02-2005 | End Date 03-04-2022 |
| Code | Start Date | End Date |
|---|---|---|
| 4483611000001102 | 04-06-2003 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Mitoxantrone hydrochloride | Based on Base Substance | Mitoxantrone | 2 mg | 1 ml |
Name
Mitoxantrone hydrochloride
Basis of strength description
Based on Base Substance
BOSS
Mitoxantrone
Strength and UOM (Nmr)
2.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMMitoxantrone
-
VMP(Current) Mitoxantrone 30mg/15ml solution for ...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 vial |